Financials in USD. Standardized financial statements.
A compact view of how Organogenesis Holdings Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $563.03M | $482.04M | $433.14M | $450.89M | $467.36M | $338.30M | $260.98M | $193.45M | $0 | $0 |
| Revenue Growth? | +16.8% | +11.3% | -3.9% | -3.5% | +38.2% | +29.6% | +34.9% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $137.52M | $115.74M | $106.48M | $105.02M | $114.20M | $87.32M | $75.95M | $68.81M | $4.59M | $208,698 |
| Gross Profit? | $425.51M | $366.30M | $326.66M | $345.87M | $353.16M | $250.98M | $185.03M | $124.64M | -$4.59M | -$208,698 |
| Gross Margin? | +75.6% | +76.0% | +75.4% | +76.7% | +75.6% | +74.2% | +70.9% | +64.4% | 0.0% | 0.0% |
| Operating Expenses? | $369.64M | $367.58M | $314.13M | $323.57M | $280.94M | $224.28M | $214.89M | $172.70M | $4.59M | $208,698 |
| Operating Income? | $55.87M | -$1.28M | $12.53M | $22.30M | $72.22M | $26.70M | -$29.85M | -$51.56M | -$4.59M | $208,698 |
| EBITDA? | $82.81M | $15.76M | $36.03M | $40.32M | $87.00M | $37.23M | -$19.74M | -$46.92M | -$2.09M | -$1.75M |
| Income Before Tax | $46.97M | -$2.81M | $10.39M | $20.28M | $63.09M | $17.76M | -$38.56M | -$64.75M | -$2.09M | -$208,698 |
| Income Tax Expense | $9.94M | -$3.67M | $5.45M | $4.75M | -$31.12M | $530,000 | $150,000 | $84,000 | -$52,516 | -$440,212 |
| Net Income? | $37.03M | $861,000 | $4.95M | $15.53M | $94.20M | $17.23M | -$38.71M | -$64.83M | -$2.09M | -$208,698 |
| EPS? | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 | $0.16 | $-0.44 | $-0.94 | $-0.03 | $-0.02 |
| Diluted EPS? | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.44 | $-0.94 | $-0.03 | $-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality